Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Wegovy is made by Novo Nordisk and was approved by the FDA in 2021
Tirzepatide is not recommended for patients with severe gastroparesis due to its effects on gastric emptying
Unlike single- or dual-pathway compounds, it is a GIP, GLP-1, and glucagon triple receptor agonist , meaning it simultaneously activates the receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon
Liraglutide has demonstrated both cardiovascular benefits in addition to its excellent glucose-lowering effects
US$ 29.04
US$ 25.19
US$ 28.26
:max_bytes(150000):strip_icc()/Health-GettyImages-2112991930-7aba42b37c8641d3a76cb03100b26dda.jpg)
US$ 21.32
US$ 23.56
